JP

Jayeshbhai Prajapati

Active Director Director DIN 07225332
DIN 07225332 First appointment Aug 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2015
Shareholding value •••• Premium profile

About Jayeshbhai Prajapati

Data last updated:

Jayeshbhai Prajapati is a Director at Vernoxy Pharma Private Limited (since 2015). The company operates in Pharma. Vernoxy Pharma Private Limited reported revenue of ₹2.61 Cr (FY 2024).

DIN 07225332
Primary Designation Director
Industry Pharma
First Appointment 12 Aug 2015
Oldest Company Age 11 yrs
Largest company Vernoxy Pharma Private Limited · ₹2.61 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vernoxy Pharma Private Limited U36934GJ2015PTC084176
Director12 Aug 20152015₹2.61 Cr (FY 2024)Active

Board colleagues of Jayeshbhai Prajapati

Directorship timeline

Open interactive timeline →
Vernoxy Pharma Private Limited
Premium access

Shareholding and investment profile for Jayeshbhai Prajapati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jayeshbhai Prajapati

Jayeshbhai Prajapati currently holds 1 directorship: Vernoxy Pharma Private Limited (Director, since 12 Aug 2015, revenue ₹2.61 Cr (FY 2024)).

Jayeshbhai Prajapati was first appointed on 12 Aug 2015 as Director at Vernoxy Pharma Private Limited.

The current boards of Jayeshbhai Prajapati's companies include Narendrabhai Harjibhai Prajapati (Vernoxy Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available